Mar 25, 2025 08:01AM
Mar 24, 2025 08:01AM
Nov 14, 2024 08:01AM
Nov 13, 2024 08:01AM
Aug 13, 2024 08:01AM
Aug 12, 2024 08:07AM
May 13, 2024 08:43PM PAVmed Provides Business Update and First Quarter 2024 Financial Results
May 13, 2024 08:00AM
Mar 26, 2024 07:32PM
Mar 25, 2024 05:31PM
Mar 25, 2024 05:30PM
Nov 14, 2023 05:43PM
Nov 13, 2023 05:55PM
Nov 13, 2023 05:40PM Lucid Diagnostics Provides Business Update and Third Quarter Financial Results
Aug 16, 2023 05:12AM
Aug 15, 2023 08:17PM
Aug 14, 2023 06:48PM
May 16, 2023 05:00PM
May 15, 2023 06:24PM
May 15, 2023 06:21PM
Apr 25, 2023 08:45AM PAVmed Digital Health Subsidiary, Veris Health, Appoints Gary Manning as President
Mar 14, 2023 07:09PM
Mar 13, 2023 06:21PM
Nov 15, 2022 04:20PM
Aug 16, 2022 04:40PM
Aug 16, 2022 04:40PM
May 12, 2022 04:38PM
Apr 27, 2022 09:46AM Cantor Fitzgerald Reiterates Overweight Rating, $12 Price Target on Lucid Diagnostics Inc (LUCD) on BeiGene's RATIONALE 306 Trial Data, "Encourage Investors to Acquire LUCD Shares at an Attractive Ent
Mar 29, 2022 04:11PM
Mar 29, 2022 07:45AM
Mar 3, 2022 08:25AM
Nov 16, 2021 04:14PM
Nov 16, 2021 04:13PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All